Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Belimumab · Benlysta, HGS1006

Monoclonal antibody · Inhibitor of B-lymphocyte stimulator (BLyS) (TNFSF13B) · developed by Human Genome Sciences

Approved FDA, Mar 2011
3 Registered trials

What is Belimumab?

Belimumab is a fully human monoclonal antibody that binds soluble B-lymphocyte stimulator (BLyS), blocking its binding to receptors on B cells. This reduces B-cell survival and their differentiation into immunoglobulin-producing plasma cells. It is used in systemic lupus erythematosus and lupus nephritis.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Benlysta, HGS1006, BEL-114333, GSK-1550188, LymphoStat-B
Drug type
Monoclonal antibody
Targets
B-lymphocyte stimulator (BLyS) (TNFSF13B)
Mechanism
Inhibitor of B-lymphocyte stimulator (BLyS) (TNFSF13B)
Pathways
B-cell survival, B-cell differentiation into immunoglobulin-producing plasma cells
Therapy area
Immunology
Developer
Human Genome Sciences Inc.
In trials of
GSK
FDA status
Approved as Benlysta (March 9, 2011), BLA125370 · FDA label
UNII
73B0K5S26A

✅ FDA-approved uses

From the indications section of the FDA label (version of Aug 21, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT01632241 Phase 4 Systemic Lupus Erythematosus Completed GSK
NCT00712933 Phase 3 Systemic Lupus Erythematosus Completed GSK
NCT01649765 Phase 2 Systemic Lupus Erythematosus Completed GSK

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Systemic Lupus Erythematosus

Other drugs acting on TNFSF13B

Sources

Updated Oct 18, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.